This link has been bookmarked by 1 people . It was first bookmarked on 12 Dec 2008, by gibreel ferishta.
-
gibreel ferishtaThe risk of India’s generic drugs being labelled counterfeit under the new definition proposed by WHO has receded, a government represe
ntative concerned with the issue said. This would ensure that India’s manufacturers continue to sell their drugs in foreign markets.
The WHO-funded International Medical Products Anti-Counterfeiting Taskforce (IMPACT) had proposed a new definition of counterfeit drugs as medical products with a “false representation about their identity, history or source”.
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.